[HTML][HTML] DTEXT–text messaging intervention to improve outcomes of people with type 2 diabetes: protocol for randomised controlled trial and cost-effectiveness …
Background Diabetes prevalence is rapidly increasing, with type 2 diabetes predicted to be
the leading contributor of non-communicable disease in Australia by 2020. It is anticipated …
the leading contributor of non-communicable disease in Australia by 2020. It is anticipated …
DTEXT-text messaging intervention to improve outcomes of people with type 2 diabetes: protocol for randomised controlled trial and cost-effectiveness analysis.
K Waller, S Furber, A Bauman… - BMC Public …, 2019 - europepmc.org
Background Diabetes prevalence is rapidly increasing, with type 2 diabetes predicted to be
the leading contributor of non-communicable disease in Australia by 2020. It is anticipated …
the leading contributor of non-communicable disease in Australia by 2020. It is anticipated …
[PDF][PDF] DTEXT-text messaging intervention to improve outcomes of people with type 2 diabetes: protocol for randomised controlled trial and cost-effectiveness analysis
K Waller, S Furber, A Bauman, M Allman-Farinelli… - 2019 - academia.edu
Background: Diabetes prevalence is rapidly increasing, with type 2 diabetes predicted to be
the leading contributor of non-communicable disease in Australia by 2020. It is anticipated …
the leading contributor of non-communicable disease in Australia by 2020. It is anticipated …
DTEXT-text messaging intervention to improve outcomes of people with type 2 diabetes: protocol for randomised controlled trial and cost-effectiveness analysis
K Waller, S Furber, A Bauman… - BMC public …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Diabetes prevalence is rapidly increasing, with type 2 diabetes predicted to be
the leading contributor of non-communicable disease in Australia by 2020. It is anticipated …
the leading contributor of non-communicable disease in Australia by 2020. It is anticipated …
[PDF][PDF] DTEXT-text messaging intervention to improve outcomes of people with type 2 diabetes: protocol for randomised controlled trial and cost-effectiveness analysis
K Waller, S Furber, A Bauman, M Allman-Farinelli… - 2019 - scholar.archive.org
Background: Diabetes prevalence is rapidly increasing, with type 2 diabetes predicted to be
the leading contributor of non-communicable disease in Australia by 2020. It is anticipated …
the leading contributor of non-communicable disease in Australia by 2020. It is anticipated …
DTEXT-text messaging intervention to improve outcomes of people with type 2 diabetes: protocol for randomised controlled trial and cost-effectiveness analysis.
K Waller, S Furber, A Bauman, M Allman-Farinelli… - BMC Public …, 2019 - go.gale.com
Background Diabetes prevalence is rapidly increasing, with type 2 diabetes predicted to be
the leading contributor of non-communicable disease in Australia by 2020. It is anticipated …
the leading contributor of non-communicable disease in Australia by 2020. It is anticipated …
[PDF][PDF] DTEXT-text messaging intervention to improve outcomes of people with type 2 diabetes: protocol for randomised controlled trial and cost-effectiveness analysis
K Waller, S Furber, A Bauman, M Allman-Farinelli… - 2019 - anzctr.org.au
Background: Diabetes prevalence is rapidly increasing, with type 2 diabetes predicted to be
the leading contributor of non-communicable disease in Australia by 2020. It is anticipated …
the leading contributor of non-communicable disease in Australia by 2020. It is anticipated …
[HTML][HTML] DTEXT–text messaging intervention to improve outcomes of people with type 2 diabetes: protocol for randomised controlled trial and cost-effectiveness …
K Waller, S Furber, A Bauman… - BMC Public …, 2019 - ncbi.nlm.nih.gov
Background Diabetes prevalence is rapidly increasing, with type 2 diabetes predicted to be
the leading contributor of non-communicable disease in Australia by 2020. It is anticipated …
the leading contributor of non-communicable disease in Australia by 2020. It is anticipated …
[HTML][HTML] DTEXT–text messaging intervention to improve outcomes of people with type 2 diabetes: protocol for randomised controlled trial and cost-effectiveness …
K Waller, S Furber, A Bauman… - BMC Public …, 2019 - bmcpublichealth.biomedcentral.com
Diabetes prevalence is rapidly increasing, with type 2 diabetes predicted to be the leading
contributor of non-communicable disease in Australia by 2020. It is anticipated that rates of …
contributor of non-communicable disease in Australia by 2020. It is anticipated that rates of …
[引用][C] DTEXT-text messaging intervention to improve outcomes of people with type 2 diabetes: protocol for randomised controlled trial and cost-effectiveness analysis
K Waller, S Furber, A Bauman, M Allman-Farinelli… - 2019 - islhd.intersearch.com.au
ISLHD Health Libraries: DTEXT - text messaging intervention to improve outcomes of people
with type 2 diabetes: protocol for randomised controlled trial and cost-effectiveness analysis Skip …
with type 2 diabetes: protocol for randomised controlled trial and cost-effectiveness analysis Skip …